A living library of credible information for patients of multiple myeloma and their caregivers.
…
continue reading
Multiple Myeloma Patients Podcasts
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
…
continue reading
Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
The International Myeloma Foundation (IMF) is the world’s first and largest myeloma organization, reaching more than 525,000 members in 140 countries. Founded in 1990, the IMF is a non-profit organization dedicated to improving the quality of life of myeloma patients and their families. The IMF funds research, provides education, lends support, and promotes advocacy initiatives that allow collective voices to be heard. The IMF’s dedicated and diverse staff provides immediate help. Our knowle ...
…
continue reading
Emergency Medicine Cases – Where the Experts Keep You in the Know. For show notes, quizzes, videos and more learning tools please visit emergencymedicinecases.com
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
Sit back and listen to Ulf-Henrik Mellqvist talking about the significant developments in the field of multiple myeloma treatment. What do the new possibilities mean for patients and doctors? And why should young doctors looking to specialize go into hematology?
…
continue reading
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
Wait How Do You Spell That? is a rare disease podcast produced by Patient Worthy. We talk about issues affecting people rare and underdiagnosed conditions and interview advocates from across the community. We‘re definitely not doctors, and we can‘t give you medical advice. We‘re just here to chat and learn about the diseases that even doctors can‘t seem to spell. Check out the latest in rare disease news at PatientWorthy.com.
…
continue reading
Physicians' Education Resource® (PER®) is committed to advancing patient care through professional education. This podcast is a natural extension of PER®'s efforts to provide medical education for health care providers to stay up to date with advances in medical care, from diagnosis through treatment, with the ultimate goal of improving patient outcomes. Visit www.gotoper.com for more information.
…
continue reading
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematolog ...
…
continue reading
Welcome to the mibo show, where we focus on mind and body wellness… let’s talk about it!!! Each episode our guests will talk about their mental and/or physical health journey or that of their family. We will also have subject matter experts talk health facts and stats, best practices for wellness, and provide strategies to encourage us all how to live a healthy lifestyle where we prioritize our mind and body wellness on a regular basis!
…
continue reading
The Cancer Revolution podcast series looks to explore all areas of integrative, traditional and alternative means of beating cancer and creating sustained good health, for the young folks and old. Our topics will include areas such as immune system, metabolic theory, epigenetic, microbial connections, diet, mitigating side effects of cancer treatments, detoxification methods, anticancer nutrition, the latest news and stories in institutional cancer research
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
1
S1 Ep190: Evolutions Across NSCLC, Multiple Myeloma, and AML at Georgia Cancer Center
13:07
13:07
Play later
Play later
Lists
Like
Liked
13:07As part of a visit to Georgia Cancer Center in Augusta, Georgia, CancerNetwork spoke with a variety of experts and faculty members regarding ongoing research and future initiatives dedicated to improving outcomes across different patient populations. These conversations touched upon potential developments in diseases including non–small cell lung c…
…
continue reading
1
Patient and Physician Perspectives on Prostate Cancer Data Presented at ASCO 2025: A Podcast
33:02
33:02
Play later
Play later
Lists
Like
Liked
33:02In this plain language podcast, highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting 2025 are discussed. These insights come from the perspective of an expert patient and physician, both of whom have experience and expertise in the field of prostate cancer. This podcast is intended to broaden the reach of complex data and…
…
continue reading
1
S1 Ep189: Decision-Making Capacity: The Ethical Core of Patient-Centered Oncology
51:46
51:46
Play later
Play later
Lists
Like
Liked
51:46In a collaborative podcast with the American Psychosocial Oncology Society hosted by Daniel C. McFarland, DO, guests Louis P. Voigt, MD, and Yesne Alici, MD, discussed the ethical and clinical complexities of assessing decision-making capacity (DMC) in oncology, emphasizing its role as the ethical core of person-centered care. The discussion began …
…
continue reading
1
Bronchiectasis Treatment Goals, Unmet Needs, and Emerging Therapies: A Podcast
30:06
30:06
Play later
Play later
Lists
Like
Liked
30:06This podcast is published open access in Pulmonary Therapy and is fully citeable. You can access the original published podcast article through the Pulmonary Therapy website and by using this link: https://link.springer.com/article/10.1007/s41030-025-00330-1. All conflicts of interest can be found online. This podcast is intended for medical profes…
…
continue reading
1
Real-World Perspectives on Switching Patients With Multiple Sclerosis From Anti-CD20 Therapy to Cladribine Tablets From
34:28
34:28
Play later
Play later
Lists
Like
Liked
34:28This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the XX website and by using this link: https://link.springer.com/article/10.1007/s12325-025-03391-5. All conflicts of interest can be found online. This podcast is intended for medical professionals.Open …
…
continue reading
1
Treatment in R/M-SCCHN in the Year 2025 - Standard and Considerations for am Individualized Treatment
47:10
47:10
Play later
Play later
Lists
Like
Liked
47:10A Podcast Discussion on Medical Treatment in R/M-SCCHN in the Year 2025—Standard and Considerations for an Individualized Treatment A Podcast Discussion on Medical Treatment in R/M-SCCHN in the Year 2025—Standard and Considerations for an Individualized Treatment In this podcast, speakers Dr Konrad Klinghammer and Dr Philipp Ivanyi discuss the gene…
…
continue reading
1
024 From Braces to Bone Regrowth: Modern Spine Care in Myeloma
52:55
52:55
Play later
Play later
Lists
Like
Liked
52:55Sean Molloy, renown spinal surgeon at the Royal National Orthopaedic Hospital (RNOH) NHS Trust in Stanmore explains how tailored bracing, breakthrough bone healing in myeloma, physiotherapy and minimally invasive vertebroplasty can transform pain, mobility and long-term spinal stability. 📌Key Takeaways: A brace can act like “nature’s own surgery”, …
…
continue reading
1
TROP2 and TIGIT Therapies for Advanced NSCLC: Where Are We Today?
20:37
20:37
Play later
Play later
Lists
Like
Liked
20:37In this episode, Benjamin Levy, MD, FASCO, and Alex Spira, MD, PhD, FASCO, discuss the latest developments in targeting TROP2 and TIGIT for the treatment of lung cancer, including: TROP2-targeting ADCs: datopotamab deruxtecan, sacituzumab govitecan, sacituzumab tirumotecan TROP2 ADCS for patients with EGFR-mutated NSCLC TIGIT-targeting agents: domv…
…
continue reading
1
S1 Ep188: How Can Chlorotoxin-Directed CAR T-Cell Therapy Impact Glioblastoma Care?
12:42
12:42
Play later
Play later
Lists
Like
Liked
12:42In a conversation with CancerNetwork®, Michael Barish, PhD, spoke about an investigational CAR T-cell therapy that he and colleagues are developing as a treatment for patients with glioblastoma. He and his team designed the agent to harness chlorotoxin, an amino acid peptide toxin component of scorpion venom, as a vehicle for intratumoral delivery …
…
continue reading
1
Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy
59:42
59:42
Play later
Play later
Lists
Like
Liked
59:42Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Manali Kamdar from the University of Colorado Cancer Center in Aurora discuss patient questions and experiences with CAR T-cell therapy for non-Hodgkin lymphoma. Educational information and select publications here.
…
continue reading
1
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
1:00:13
1:00:13
Play later
Play later
Lists
Like
Liked
1:00:13Dr Matthew Lunning and Dr Sonali M Smith share their perspectives on the evolving therapeutic landscape for patients with diffuse large B-cell lymphoma and follicular lymphoma. CME information and select publications here.
…
continue reading
1
Ep 209 Nondisabling Stroke Recognition and Management
1:19:30
1:19:30
Play later
Play later
Lists
Like
Liked
1:19:30In this Part 2 or our 2-part podcast update on ED stroke management with Dr. Katie Lin and Dr. Walter Himmel we explore non-disabling strokes, where symptoms are mild enough that patients can continue daily activities if deficits persist. Yet, non-disabling does not mean benign. Non-disabling strokes occupy the same ischemic continuum as TIAs and c…
…
continue reading
1
S1 Ep187: How Supportive Care Methods Can Improve Oncology Outcomes
26:03
26:03
Play later
Play later
Lists
Like
Liked
26:03The latest episode of Oncology On the Go focused on survivorship and supportive care. Stemming from conversations with leading clinicians in the field, the compilation highlights gaps and educational insights into multiple areas. Covering topics like nutrition, oncodermatology, body image, sexual health, and mortality, these conversations explored …
…
continue reading
1
A Newly Approved Targeted Combination Therapy for KRAS-Mutant Low-Grade Serous Ovarian Cancer
22:14
22:14
Play later
Play later
Lists
Like
Liked
22:14In this episode, Dr Rachel Grisham and Dr Kathleen Moore discuss newly approved treatments for low-grade serous ovarian cancer (LGSOC) and how recent research has transformed the therapeutic landscape for these patients, including: Molecular distinctions between low-grade and high-grade serous ovarian cancer that can guide therapy selection The rec…
…
continue reading
1
023 Numbness, Tingling and Treatment: Making Sense of Neuropathy
35:30
35:30
Play later
Play later
Lists
Like
Liked
35:30Dr Jam & Sally unpack what neuropathy is, why it happens in myeloma treatment, and how patients can recognise, prevent and manage it to protect their quality of life. 📌Key Takeaways: Know the signs early – tingling, numbness or pain shouldn’t be ignored; speak up before symptoms worsen. Treatment can be adjusted – modern dosing and combinations mak…
…
continue reading
1
CDH6-Targeting Antibody–Drug Conjugates in Ovarian Cancer: A Promising Treatment Approach
26:01
26:01
Play later
Play later
Lists
Like
Liked
26:01In this episode, Kathleen N. Moore, MD, MS, FASCO, and Isabelle Ray-Coquard, MD, PhD, discuss the emerging role of CDH6-targeting antibody–drug conjugates (ADCs) for ovarian cancer, including: Results of the phase I trial of raludotatug deruxtecan (R-DXd) in ovarian cancer Results of the phase II REJOICE-Ovarian01 study in patients with platinum-re…
…
continue reading
1
S1 Ep186: How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
29:03
29:03
Play later
Play later
Lists
Like
Liked
29:03Following a fruitful European Society of Medical Oncology (ESMO) Congress 2025 for gastrointestinal malignancies, CancerNetwork® organized an X Spaces discussion hosted by 3 experts. They were Nicholas J. Hornstein, MD, an assistant professor at the Donald and Barbara Zucker School of Medicine of Hofstra University and Northwell Health; Timothy Bro…
…
continue reading
1
Living with Eosinophilic Granulomatosis with Polyangiitis (EGPA): Podcast of a Patient-Physician Discussion
31:42
31:42
Play later
Play later
Lists
Like
Liked
31:42Living with Eosinophilic Granulomatosis with Polyangiitis (EGPA): Podcast of a Patient-Physician DiscussionThis podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007…
…
continue reading
1
Transforming Care in Cutaneous Squamous Cell Carcinoma: Integrating Immunotherapy Into Patient Care
35:16
35:16
Play later
Play later
Lists
Like
Liked
35:16In this podcast, Dr David Miller, MD, PhD, FAAD and Dr Vishal Patel, MD discuss the evolving treatment landscape and immunotherapeutic strategies for cutaneous squamous cell carcinoma (cSCC) based on key data from pivotal studies that are reshaping standards of care, including: Trials of neoadjuvant immunotherapies demonstrating remarkable response…
…
continue reading
1
Ep 208 Paradigm Shift in Ischemic Stroke Management Part 1: Disabling Strokes
1:36:12
1:36:12
Play later
Play later
Lists
Like
Liked
1:36:12We are amidst a paradigm shift in the emergency management of acute ischemic stroke. The traditional way of categorizing ischemic strokes as 'minor' vs 'major' is no longer relevant to what we do in the ED. It's now about 'disabling' vs 'non-disabling' strokes. And this is no small change. This categorization dictates urgency of ED work-up and trea…
…
continue reading
1
Paroxysmal Nocturnal Hemoglobinuria: Translating Pathobiology Into Modern Clinical Management
27:48
27:48
Play later
Play later
Lists
Like
Liked
27:48In this educational podcast discussion, Carlos M. De Castro, MD, and David Dingli, MD, PhD, FRCP, FRCPEd, FACP, FRCPath, explore paroxysmal nocturnal hemoglobinuria (PNH). They trace the evolution of treatment from early complement inhibitors to today’s expanding therapeutic options, emphasizing how these advances have transformed patient outcomes …
…
continue reading
1
S1 Ep185: What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
11:31
11:31
Play later
Play later
Lists
Like
Liked
11:31As part of the European Society for Medical Oncology (ESMO) Congress 2025, CancerNetwork® spoke with a variety of experts about key takeaways from different late-breaking abstracts, oral presentations, and other sessions focused on potential advancements across cancer care. Presenting investigators highlighted updated results from clinical trials e…
…
continue reading
1
Exploring two new, validated disease specific outcome measures to assess severity of Chronic Hand Eczema
29:21
29:21
Play later
Play later
Lists
Like
Liked
29:21This podcast is published open access in Dermatology and Therapy and is fully citeable. You can access the original published podcast article through the Dermatology and Therapy website and by using this link:https://link.springer.com/article/10.1007/s13555-025-01551-7. All conflicts of interest can be found online. This podcast is intended for med…
…
continue reading
1
Acute Myeloid Leukemia — An Interview with Dr Eunice S Wang to Review Key Presentations from ASCO and EHA
54:59
54:59
Play later
Play later
Lists
Like
Liked
54:59Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discusses recent datasets and their implications for the current and future management of acute myeloid leukemia. CME information and select publications here.
…
continue reading
1
Patient and Physician Perspectives on Multiple Myeloma Data Presented at ASCO and EHA 2025: A Podcast
45:25
45:25
Play later
Play later
Lists
Like
Liked
45:25In this plain language podcast, highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting 2025 are discussed, supplemented with additional reflections from the European Hematology Association (EHA) 2025 Congress. These insights come from the perspective of an expert patient and physician, both of whom have experience and exper…
…
continue reading
1
022 Remission, Relapse and Reality Understanding the R-Words in Myeloma
33:07
33:07
Play later
Play later
Lists
Like
Liked
33:07Dr Jam & Sally unpack what remission, relapse and refractory disease truly mean for people living with myeloma — and explore how close we are to talking about cure. 📌Key Takeaways: Remission ≠ cure – myeloma can be controlled for years, even if it never fully disappears. Monitoring matters – blood tests, bone marrow checks and scans together tell t…
…
continue reading
1
S1 Ep184: Leveraging Biology to Advance the Small Cell Lung Cancer Treatment Paradigm
13:12
13:12
Play later
Play later
Lists
Like
Liked
13:12In a discussion with CancerNetwork®, Anne Chiang, MD, PhD, spoke about the current treatment landscape for those with small cell lung cancer (SCLC) as well as next steps for elevating the quality of care among patients. She began by outlining the evolution of therapeutic standards in the field, with atezolizumab (Tecentriq)- and durvalumab (Imfinzi…
…
continue reading
1
Non-Hodgkin Lymphoma — The Implications of Recent Datasets for Current and Future Disease Management
57:59
57:59
Play later
Play later
Lists
Like
Liked
57:59Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, and Dr Brad S Kahl from Siteman Cancer Center in St Louis, Missouri, review recent datasets and their significance for the management of various forms of non-Hodgkin lymphoma. CME information and select publications here.
…
continue reading
1
Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
26:10
26:10
Play later
Play later
Lists
Like
Liked
26:10In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-negative early breast cancer including insights on identifying high-risk disease considering clinical/pathological factors and gene expression assays and answering healthcare professional questions on h…
…
continue reading
1
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
23:57
23:57
Play later
Play later
Lists
Like
Liked
23:57In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-negative metastatic breast cancer including the current treatment algorithm, implementing genomic testing for assessing molecular resistance and guiding treatment decisions, and answering healthcare pro…
…
continue reading
1
HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options
37:10
37:10
Play later
Play later
Lists
Like
Liked
37:10In this podcast episode, Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss new and emerging therapies for the personalized care of patients with HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancer (BTC), including: Brief overview of BTC and GEA Approved HER2-directed therapies for BTC and GEA and their mechanisms of acti…
…
continue reading
1
S1 Ep183: Charting the Evolution of TKIs and Finding the Next Breakthrough in CML
17:57
17:57
Play later
Play later
Lists
Like
Liked
17:57In a conversation with CancerNetwork®, Jorge Cortes, MD, explored the evolution of the chronic myeloid leukemia (CML) landscape. Specifically, he highlighted how the development of ibrutinib (Gleevec) paved the way for other tyrosine kinase inhibitors (TKIs) and described where research must go next in terms of implementing fixed-duration therapy a…
…
continue reading
1
The Phase 2b COPERNICUS Study of Subcutaneous Amivantamab with Lazertinib for EGFR-Mutated NSCLC
18:46
18:46
Play later
Play later
Lists
Like
Liked
18:46The Phase 2b COPERNICUS Study of Subcutaneous Amivantamab with Lazertinib as First-Line Treatment, or with Chemotherapy as Second-Line Treatment, for EGFR-Mutated Non-Small Cell Lung Cancer: a Vodcast The Phase 2b COPERNICUS Study of Subcutaneous Amivantamab with Lazertinib as First-Line Treatment, or with Chemotherapy as Second-Line Treatment, for…
…
continue reading
1
Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
59:34
59:34
Play later
Play later
Lists
Like
Liked
59:34Dr Jeremy S Abramson from Massachusetts General Hospital in Boston, Dr Jennifer Crombie from Dana-Farber Cancer Institute also in Boston and Dr Laurie H Sehn from the BC Cancer Centre for Lymphoid Cancer in Vancouver, British Columbia, Canada, discuss recent updates on available and novel treatment strategies for follicular lymphoma. CE informatio…
…
continue reading
1
Acute Myeloid Leukemia — An Interview with Dr Ghayas Issa on the Role of Menin Inhibitors
58:47
58:47
Play later
Play later
Lists
Like
Liked
58:47Dr Ghayas Issa from The University of Texas MD Anderson Cancer Center in Houston discusses data guiding the use of menin inhibitors for patients with acute myeloid leukemia and select alterations. CME information and select publications here.
…
continue reading
1
021 Understanding Risk in Myeloma: What Your Genetics Can Tell You
36:31
36:31
Play later
Play later
Lists
Like
Liked
36:31This episode unpacks the complex world of myeloma genetics - what high and standard risk really mean, how these tests guide treatment, and how future advances could lead to truly personalised care with Sarah Gooding. Sarah is a colleague, and an Honorary Consultant Haematologist, based in Oxford. 📌Key Takeaways: Your myeloma is unique - genetic tes…
…
continue reading
1
EM Quick Hits 68 Osteomyelitis, Tourniquet Technique, Pediatric Distal Radius Buckle Fractures, DSI RCT, AMS in ESRD & Dialysis, EM Leadership Spotlight #3
1:25:12
1:25:12
Play later
Play later
Lists
Like
Liked
1:25:12By Dr. Anton Helman
…
continue reading
1
S1 Ep182: Optimizing Care for TILs, Cellular Therapy in Melanoma and Solid Tumors
26:30
26:30
Play later
Play later
Lists
Like
Liked
26:30In a special co-branded episode between Oncology On the Go, hosted by CancerNetwork®, and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program, ASTCT Talks, for American Pharmacists Month, a panel of oncology pharmacists discussed optimal strategies for using cellular therapies as treatment for patients with solid tumors.…
…
continue reading
1
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
58:29
58:29
Play later
Play later
Lists
Like
Liked
58:29Prof Meletios-Athanasios (Thanos) C Dimopoulos from Alexandra Hospital in Athens, Greece, Dr Hans Lee from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Joseph Mikhael from City of Hope Cancer Center in Phoenix, Arizona, and Dr Noopur Raje from Massachusetts General Hospital in Boston discuss recent updates on available and novel trea…
…
continue reading
1
Podcast Synopsis of Updates to the European Renal Best Practice and UK Kidney Association Guidelines for Treatment of An
39:22
39:22
Play later
Play later
Lists
Like
Liked
39:22This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007/s12325-025-03366-6. All conflicts of interest can be found online. This podcast is intended for medical pr…
…
continue reading
1
S1 Ep181: Gemcitabine Intravesical System Offers Tremendous Benefits in NMIBC
17:02
17:02
Play later
Play later
Lists
Like
Liked
17:02In a conversation with CancerNetwork® following the FDA approval of the gemcitabine intravesical system (Inlexzo; formerly TAR-200) for patients with high-risk, Bacillus Calmette-Guérin (BCG)–unresponsive non–muscle-invasive bladder cancer (NMIBC), Gary Steinberg, MD, discussed how this regulatory decision may impact the treatment paradigm. Steinbe…
…
continue reading
1
020 Myeloma UK at the Heart: Advocacy, Research and Hope
37:47
37:47
Play later
Play later
Lists
Like
Liked
37:47This episode features Dr Sophie Castell, CEO of Myeloma UK, sharing insights into the charity’s vital work in research, advocacy, patient support, and tackling inequalities in myeloma care. 📌Key Takeaways: Survival rates for myeloma have quadrupled — and living well is now as important as living longer. Myeloma UK drives progress from early diagnos…
…
continue reading
1
Lung Health & RSV: Podcast of a Patient–Physician Discussion Based on Insights from a Patient Advisory Board Meeting
30:18
30:18
Play later
Play later
Lists
Like
Liked
30:18Lung Health and Respiratory Syncytial Virus: Podcast of a Patient–Physician Discussion Based on Insights from a Patient Advisory Board MeetingThis podcast is published open access in Infectious Diseases and Therapy and is fully citeable. You can access the original published podcast article through the Infectious Diseases and Therapy website and by…
…
continue reading
1
S1 Ep180: How To Discuss Death? A Conversation of Mortality in Cancer Care
48:48
48:48
Play later
Play later
Lists
Like
Liked
48:48In the recent episode of Oncology-on-the-Go, in collaboration with the American Psychosocial Oncology Society (APOS), Daniel C. McFarland, DO, welcomes William S. Breitbart, MD, to discuss how clinicians can address patients’ existential concerns. While oncologists often focus on treatment and the drive for life, the core concern for many patients …
…
continue reading
1
Oncology Nursing Update: Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy
53:08
53:08
Play later
Play later
Lists
Like
Liked
53:08Dr Beth Faiman from Case Comprehensive Cancer Center in Cleveland, Ohio, discusses nursing considerations with CAR T-cell therapy for patients with multiple myeloma. NCPD information and select publications here.
…
continue reading
1
The Role of Oncology Nurses and Advanced Practice Providers in the Treatment of Patients With HRR-Deficient mCRPC
27:24
27:24
Play later
Play later
Lists
Like
Liked
27:24The Role of Oncology Nurses and Advanced Practice Providers in the Treatment of Patients With HRR-Deficient mCRPC Receiving Talazoparib Plus Enzalutamide: A Podcast The Role of Oncology Nurses and Advanced Practice Providers in the Treatment of Patients With HRR-Deficient mCRPC Receiving Talazoparib Plus Enzalutamide: A Podcast The objective of thi…
…
continue reading
1
Managing Drug Interactions with Enzalutamide in Patients with Prostate Cancer: A Podcast
25:38
25:38
Play later
Play later
Lists
Like
Liked
25:38strong textBy Alicia K. Morgans, Brooke Looney, Jesse Mack, Judeth Bianco
…
continue reading
1
Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management
54:23
54:23
Play later
Play later
Lists
Like
Liked
54:23Dr Neel Pasricha from the University of California, San Franciso, reviews corneal and other ophthalmic toxicities associated with antibody-drug conjugates and other cancer therapies and strategies for their prevention and management. CME information and select publications here.
…
continue reading
1
Ep 207 Sleep Strategies for Shift Work
1:21:04
1:21:04
Play later
Play later
Lists
Like
Liked
1:21:04Discover evidence-based sleep strategies for shift workers. Optimize performance, recovery, and health with tips from sleep expert Dr. Michael Mak... If you find this beneficial please consider a donation to support EM Cases: https://emergencymedicinecases.com/donation/By Dr. Anton Helman
…
continue reading
1
Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 1 — Inside the Issue of Adverse Event Management
57:47
57:47
Play later
Play later
Lists
Like
Liked
57:47Prof Rebecca A Dent from National Cancer Centre Singapore, Dr Hans Lee from Sara Cannon Research Institute in Nashville, Tennessee, Dr Neel Pasricha from the University of California, San Francisco, and Dr Tiffany A Richards from The University of Texas MD Anderson Cancer Center in Houston, discuss strategies to manage ocular toxicities associated …
…
continue reading